Adult onset hallervorden-spatz disease with psychotic symptoms

Actas Espanolas de Psiquiatria

Volumn 39, Issue 4, 2011, Pages 260-262

  Del Valle López, Pilar ^a   Perez Garcia, Rosa ^a   Sanguino Andres, Rosa ^b   González Pablos, Emilio ^a  

^a Otorhinolaryngology Head and Neck Surgery Department   (Spain)

^b Clinical Psychologist Complcjo Hospitalario ^*  (Spain)

Author keywords

Basal ganglia; Hallervorden spatz; Late onset; Psicosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PSYCHOSIS;

ADULT; HUMANS; MALE; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PSYCHOTIC DISORDERS;

EID: 80053265559     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pascual Gómez J. Enfermedades degenerativas del sistema nervioso. In: Rodes J, Guardia J. Medicina Interna, Tomo II. Barcelona: Masson, 1997.
2. Jhou B, Westaway SK, Levinson B, et al. A novel pantothenate Kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genetics 2001 ;28:345-9. (Pubitemid 32702423)
3. Hayflick SJ, Westaway SK, Levinson B, et al. Genetical, clinical and radiographic delineation and Hallervorden Spatz Syndrome. N Engl Med 2003;348:33-40. (Pubitemid 36026344)
4. Morphy MA, Feldman JA, Kilburn G. Hallervorden-Spatz disease in a psychiatric setting. J Clin Psychiatry 1989;50:66-8. (Pubitemid 19072976)
5. Öner Ö, Öner P. Psychotic disorder in a case with Hallervorder- Spatz disease. Act Psychiatr Scand 2003;108:394-8.
6. Panas M.Spngos, et al. Psychosis as presenting symptomsin adult onset Hallervorden-Spatz syndrome. Acta neuropsychiatrica 2007;19:122-4.
7. Sunwoo YK, Lee JS, Kim WH, Shin YB, Lee MJ, Cho IH, et al. Psychiatric Disorder in Two Siblings with Hallervorden-Spatz Disease. Psychiatry Invest 2009;6:226-9.
8. Bonelli RM, Cummings JL Frontal subcortical circuitry and behavior. Dialogues Clinic Neurosc 2007;9(2):141-51.
9. Benes FM. Emerging principles of altered neuronal circuitry in schizophrenia. Brain Research Reviews 2000;31:251-69. (Pubitemid 30136180)
10. Sadock BJ, Sadock VA. Kaplan-Sadock. Sinopsis de Psiquiatria. Novena edición. Barcelona: Waverly Hispanica, 2004.
11. Belger A, Dichter G. Neuroanatomia estructuraly funcional. En: Lieberman JA, Stroup TS, Perkins DO. Tratado de esquizofrenia. Barcelona: Ars Medica, 2008.
12. Taber KH, Hurley RA. Neuroanatomia para el psiquiatra. In: Hales RE, Yudofsky SC, Gabbard GO. Tratado de Psiquiatria Clinica. Barcelona: Elsevier, 2009.
13. Pearson RCA. Neuroanatomia. En: Gelder MG, López-lbor JJ, Andreasen N. Tratado de psiquiatria. Tomo I. Barcelona: Ars Medica 2003.
14. Cummings JL Organic delusions: phenomenology, anatomical correlations, and review. British Journal of Psychiatry 1985;146:184-97. (Pubitemid 15162125)
15. Ron MA. Psychiatric manifestations of demonstrable brain disease. Ron MA, David AS. Disorders Of Brain and Nind, 177-95 Cambridge: Cambridge University Press, 1998.
16. Cummings JL Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 1991;39:708-16.
17. Anderson KE. Enfermedad de Huntington y trastornos relacionados. Psychiatr Clin N Am 2005;28:275-290.
18. Wolter EC, Berendse MW. Management of psychosis in Parkinson's disease. Curr Opin Neurol 2001;14:499-504.
19. Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 1999;340:757-63.
20. Weintraub D, Hurtig HI. Manifestation y manejo de la psicosis en la enfermedad de Parkinson y la demencia con cuerpos de Lewy. Am J Psychiatry (Ed Esp) 2008;11(1):27-34.
21. Bonelli R, Wenning G, Kapfhammer H. Huntington's disease: present treatments and future therapeutic modalities. Int Clin Psychopharmacol2004;19(2) :51-62. (Pubitemid 38316763)